Zhilong Huoxue Tongyu capsule (ZLHX) is a traditional Chinese medicine that shows promise in treating aspirin resistance (AR), but its mechanisms are not well understood.
This study evaluated how ZLHX affects AR in rats by analyzing blood samples and using various tests to measure lipid levels and platelet aggregation.
Results indicated that ZLHX reduced platelet aggregation, improved lipid profiles, and altered the expression of specific microRNAs, suggesting its therapeutic effects are linked to lipid metabolism and genetic regulation.